Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.76156 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.73608 | 32 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.73642 | 32 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.67872 | 32 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.66404 | 31 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.7911 | 31 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.77757 | 32 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.84397 | 37 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.70026 | 32 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.71304 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.72275 | 32 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.68579 | 32 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.73144 | 32 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.72597 | 32 |